A comprehensive data analysis conducted by Ye et al. (2022) demonstrated that METTL3-mediated m6A modification on CAT, ERBB2, P2RY8, PLAUR, and TIMP1 mRNA influences immune cell infiltration, subsequently promoting ccRCC progression. Here, METTL3 is linked to nonpapillary renal cell carcinoma.